Jk. Lacki et al., ACUTE-PHASE RESPONSE IN EARLY REFRACTORY RHEUMATOID-ARTHRITIS - LONG-TERM FOLLOW-UP-STUDY, Journal of investigational allergology & clinical immunology, 4(4), 1994, pp. 168-171
In order to investigate the role of the acute-phase response in early
rheumatoid arthritis (RA), we followed the changes of alpha1-acid glyc
oprotein (AGP), alpha1-antitrypsin (AT) and alpha1-antichymotrypsin (A
CT) in the sera of 25 patients with refractory rheumatoid arthritis (R
A) during the first 3 years of the disease. Serum levels of AGP, ACT a
nd AT were measured using rocket immunoelectrophoresis, and AGP, ACT a
nd AT microheterogeneities were performed using two-dimensional immuno
electrophoresis with concanavalin A (Con A ) as ligand. On average, se
rum levels of AGP, ACT and AT proteins were higher at the onset of the
disease as compared with healthy controls. After 3 years, a significa
nt decrease in serum levels of all three acute-phase proteins (APPs) w
as observed, but only in patients without anatomical progression was t
his decrease statistically significant. At the beginning of the study,
only the AT reactivity coefficient (RC) was decreased in comparison w
ith healthy subjects. However, after 3 years of disease, AGP, ACT and
AT RCs all decreased. This investigation provided two new observations
. The first is that only AT RC is significantly lower in comparison wi
th normal values at the beginning of RA, whereas AGP RC and ACT RC rem
ain within the normal range of values; a decrease in AGP RC and ACT RC
appeared later. The second observation is that the highly elevated le
vels of APPs at the onset of RA decrease during the course of the dise
ase. Moreover, this decrease does not depend on the disease activity,
but a relationship with radiological progression was shown.